Fatigue after stroke

Therapy

Volumn 2, Issue 6, 2005, Pages 865-869

  Tyrrell, P J ^a   Smithard, David G ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b WILLIAM HARVEY HOSPITAL   (United Kingdom)

Author keywords

Fatigue; Interleukin 1; Proinflammatory cytokines; Sickness behavior; Stroke

Indexed keywords

ANTIINFLAMMATORY AGENT; ERYTHROPOIETIN; GLUTAMIC ACID; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MEGESTROL; N ACETYLASPARTIC ACID; PSYCHOSTIMULANT AGENT;

ANEMIA; ARTICLE; BRAIN RADIOGRAPHY; BREAST CANCER; CEREBROVASCULAR ACCIDENT; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FOLLOW UP; GLASGOW OUTCOME SCALE; HUMAN; ILLNESS BEHAVIOR; MORTALITY; MUSCLE FATIGUE; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; PHYSICAL ACTIVITY; PHYSIOTHERAPY; PROTEIN FUNCTION; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; QUALITY OF LIFE; RANKIN SCALE; RELAXATION TRAINING; RISK ASSESSMENT; RISK FACTOR; SLEEP PATTERN; SLEEP THERAPY; SOCIAL SUPPORT; SOFT TISSUE RADIOGRAPHY; TREATMENT OUTCOME;

EID: 28344433853     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.1586/14750708.2.6.865     Document Type: Article

References (54)

1. Van der Werf SP, van den Broek HL, Anten HW, Bleijenberg G. Experience of severe fatigue long after stroke and its relation to depressive symptoms and disease characteristics. Eur. Neurol. 45, 28-33 (2001).
2. de Groot MH, Phillips SJ, Eskes GA. Fatigue associated with stroke and other neurologic conditions: implications for stroke rehabilitation. Arch. Phys. Med. Rehab. 84, 1714-1720 (2003).
3. Staub F, Bogousslavsky J. Fatigue after stroke: a major but neglected issue. Cerebrovasc. Dis. 12(2), 75-81 (2001).
4. Warlow C, Dennis M, van Gijn J, Sandercock PAG. Bamford JM. Wardlaw J. A practical approach to the management of stroke patients. In: Stroke: A Practical Guide to Management (2nd Edition). Warlow C, Dennis M, van Gijn J (Eds). Blackwell Science, Oxford, UK (2001).
5. Chaudhuri A, Behan PO. Fatigue in neurological disorders Lancet 363, 978-988 (2004).
6. Branas P, Jordan R, Fry-Smith A, Burls A, Hyde C. Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technol. Assessment 4, 1-61 (2000).
7. Friedman J, Friedman H. Fatigue in Parkinson's disease. Neurology 43, 2016-2019 (1993).
8. Alves G, Wentzel-Larsen T, Larsen JP. Is fatigue an independent and persistent symptom in patients with Parkinson's disease? Neurology 63, 1908-1911 (2004).
9. Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K. Neuropsychiatric events in systemic lupus erythematosis: attribution and clinical significance. J. Rheumatol. 2093-2098 (2004).
10. Bruno RL. Paralytic versus non-paralytic polio: a distinction without a difference? Am. J. Phys. Med. Rehabil. 79, 4-12 (1999).
11. Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults Lancet 362, 640-650 (2003).
12. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J. Clin. Oncol. 4, 743-753 (2000).
13. White PD, Thomas JM, Sullivan P, Buchwald D. The nosology of sub-acute and chronic fatigue syndromes that follow infectious mononucleosis. Psychological Medicine 34, 499-507 (2004).
14. Roding J, Lindstrom B, Malm J, Ohman A. Frustrated and invisible-younger stroke patients' experiences of the rehabilitation process Disabil. Rehabil. 25(15), 867-874 (2003).
15. Carlsson GE, Muller A, Blomstrand C. A qualitative study of the consequences of 'hidden dysfunctions' one year after a mild stroke in persons <75 years. Disabil. Rehabil. 26, 1373-1380 (2004).
16. Choi-Kwon S, Han SW, Kwon SU, Kim JS. Post-stroke fatigue: characteristics and related factors Cerebrovasc. Dis. 19(2), 84-90. (2004) (E-pub ahead of print).
17. Ingles JL, Eskes GA, Phillips SJ. Fatigue after stroke. Arch. Phys. Med. Rehab. 80, 173-178 (1999).
18. Glader E-L, Stegmayr B, Asplund K. Poststroke fatigue: a 2 year follow-up of stroke patients in Sweden. Stroke 33, 3127-3138 (2002).
19. Hopman WM, Verner J. Quality of life during and after in-patient rehabilitation. Stroke 34, 801-805 (2003).
20. Morley W, Jackson K, Mead GE. Post-stroke fatigue: an important yet neglected symptom (letter). Age Ageing 34, 313 (2005).
21. Carlsson GE, Miller A, Blomstrad C. Consequences of mild stroke in persons <75 years: a 1 year follow-up. Cerebrovasc. Dis. 16, 383-388 (2003).
22. Powell J, Kitchen N, Heslin J, Greenwood R. Psychosocial outcomes at 18 months after good neurological recovery from aneurysmal subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry 75, 1119-1124 (2004).
23. Naess H, Nyland HI, Thomassen L, Aarseth J, Myhr K-M. Fatigue at long-term follow-up in young adults with cerebral infarction. Cerebrovasc. Diseases 20, 245-250 (2005).
24. Buck D, Jacoby A, Massey A, Steen N, Sharma A, Ford GA. Development and validation of NEWSQOL, the Newcastle Stroke specific Quality of Life measure. Cerebrovasc. Dis. 17, 143-152 (2004).
25. Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM. The revised Piper fatigue scale: psychometric evaluation in women with breast cancer. Oncol. Nurs. Forum 25, 677-684 (1998).
26. Schwartz AL. The Schwartz Cancer Fatigue Scale: testing reliability and validity. Oncol. Nurs. Forum 25, 711-717 (1998).
27. Jacobsen PB. Assessment of fatigue in cancer patients. J. Natl. Inst. Monogr. 32, 93-97 (2004).
28. Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res. 36, 291-298 (1991).
29. Bentall RP, Wood GC, Marrinan T, Deans C, Edwards RH. A brief mental fatigue questionnaire. Br. J. Clin. Psychol. 32, 375-379 (1993).
30. Staub F, Bogousslavsky J Post stroke depression or fatigue? Eur. Neurol. 45, 3-5 (2001).
31. Dantzer R. Cytokine induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur. J. Pharmacol. 500, 399-411 (2004).
32. Cleeland CS, Bennet GJ, Dantzer R, et al. Are the symptoms of cancer and cancer treatment due to a shared biological mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 97, 2919-2925 (2003).
33. Emsley H, Tyrrell P. Review: inflammation and infection in Clinical Stroke. J. Cereb. Blood Flow Metabolism 22, 1399-1419 (2002).
34. Emsley HC, Smith CJ, Gavin CM, et al. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J. Neuroimmunol. 139, 93-101 (2003).
35. Smith CJ, Emsley H CA, Gavin CM, et al. Peak plasma interleukin-6and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurology 4, 2 (2004).
36. Ronnback L, Hansson E. On the potential role of glutamate transport in mental fatigue. J. Neuroinflammation 1, 22 (2004).
37. Chaudhuri A, Behan PO In vivo magnetic resonance spectroscopy in chronic fatigue syndrome. Prostaglandins Leukot. Essent. Fatty Acids 71, 181-183 (2004).
38. Okada T, Tanaka M, Kuratsune H, Watanabe Y, Sadato N. Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome. BMC Neurology 4, 14 (2004).
39. Saleh A, Schroeter M, Jonkmanns C, Hartung P, Modder U, Jander S. In vivo MRI of brain inflammation in human ischaemic stroke. Brain 127, 1670-1677 (2004).
40. Gerhard A, Schwarz J, Myers R, Wise R, Banati RB. Evolution of microglial activation after ischemic stroke: a [11C] (R)-PK11195 study. Neuroimage 24, 591-595 (2005).
41. Kaiser LG, Schuff N, Cashdollar N, Weiner MW. Age-related glutamate and glutamine concentration changes in normal human brain: 1H MR spectroscopy study at 4T. Neurobiol. Aging 26, 665-672 (2005).
42. Wallman KE, Morton AR, Goodman C, Grove R, Guilfoyle AM. Randomised controlled trial of graded exercise in chronic fatigue syndrome. Med. J. Aust. 180, 437-438 (2004).
43. Edmonds M, McGuire H, Price J. Exercise therapy for chronic fatigue syndrome. Cochrane database Syst Rev CD003200 (2004).
44. American College of Sports Medicine. ACSM's exercise management for persons with chronic diseases and disabilities. Human Kinetics, IL, USA (1997).
45. Courneya KS, Friedenreich CM. Physical exercise and quality of life following cancer diagnosis: a literature review. Ann. Behav. Med. 21, 171-179 (1999).
46. Windsor PM, Nicoll KF, Potter J. A randomised, controlled trial of aerobic exercise for treatment related fatigue in men receiving radical external beam radiotherapy for localised prostate carcinoma. Cancer 101, 550-557 (2004).
47. Chalder T, Wallace P, Wessely S. Self-help treatment of chronic fatigue in the communiry: a randomised controlled trial. Br. J. Health Psychol. 2, 189-197 (1997).
48. Candy B, Chalder T, Cleare AJ, Wessely S, Hotopf M. A randomised controlled trial of a psychoeducatonal intervention to aid recovery in infectious mononucleosis. J. Psychsom. Res. 57, 89-94 (2004).
49. Blacker CV, Greenwood DT, Wesnes KA et al. Effect of galantamine hydrobromide in chronic fatigue symdrome: a randomized controlled trial. JAMA 292, 1195-1204 (2004).
50. Karlson EW, Liang MH, Eaton H et al. A randomised controlled trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosis. Arth. Rheum. 50, 1832-1841 (2004).
51. Bruera E, Driver L, Barnes EA et al. Patient-controlled methyl-phenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J. Clin. Oncol 21, 4439-4443 (2003).
52. Rabkin JG, McElhiney MC, Rabkin R, Ferrando SJ. Modafanil treatment for fatigue in HIV+ patients: a pilot study. J. Clin. Psychiatry 65, 1688-1695 (2004).
53. Romani A, Bergamaschi R, Candeloro E, Alfonsi E, Callieco R, Cosi V. Fatigue in multiple sclerosis: multidimensional assessment and response to symptomatic treatment. Mult. Scler. 4, 462-468 (2004).
54. Emsley HCA, Smith CJ, Georgiou RF et al. A Randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J. Neurol. Neurosurg. Psychiatry 76(10), 1366-1372 (2005).